Skip to content
CEpartner4U
  • Welcome
  • About us
    • Team
    • Jobs
  • Services
    • AR/EC Rep
    • Regulatory affairs
    • Quality system
    • CE/QMS Entry Packages©
    • Clinical evaluation
    • Training
  • UKCApartner4U
  • Information
    • F.A.Q. AR/EC Rep
    • Links
  • Library
  • News
  • Network
  • Contact

About:m.vandervoort

Posts by m.vandervoort :

  • Version 4 of the European manual on borderline and classification for medical devices and IVDs, 16 September 2025 in Uncategorized
  • MDCG issues version 4 of MDCG 2020-16: Guidance on Classification Rules IVDR, 18 March 2025 in Uncategorized
  • MDCG 2019-6 revision 5 issued: Q&A on requirements relating to notified bodies, 5 February 2025 in Uncategorized
  • IMDRF issues Characterization Considerations for Medical Device Software and Software-Specific Risk, 29 January 2025 in Uncategorized
  • MDCG 2021-12 FAQ on EMDN – Rev.1, 15 January 2025 in Uncategorized
  • MDCG 2024-2 Revision 1 published on Procedures for the updates of the European Medical Device Nomenclature, 15 January 2025 in Uncategorized
  • MDCG 2024-6, 7, 8 and 9 – Preliminary (re-)assessment review form templates published, 10 January 2025 in Uncategorized
  • MDCG issued 2023-3 Revision 2: Q&A on vigilance terms and concepts MDR-IVDR, 7 January 2025 in Uncategorized
  • MDCG publishes revision 1 of guidance (2022-3) concerning the verification of manufactured class D IVDs by notified bodies, 18 December 2024 in Uncategorized
  • Revision 1 issued of MDCG 2019-13 on sampling MDR and IVDR for the assessment of the technical documentation, 17 December 2024 in Uncategorized
  • 1
  • 2
  • 3
  • …
  • 12
  • »

Stay informed

Please check your inbox or spam box to confirm

Copyright 2026 CEpartner4U | Esdoornlaan 13 | 3951 DB Maarn | The Netherlands | +31.6.516.536.26 | office@cepartner4u.com
  • enEnglish